PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. (2023)
Attributed to:
Antisense Oligonucleotide Therapy for Neuromuscular Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202317683
PubMed Identifier: 37724723
Publication URI: http://europepmc.org/abstract/MED/37724723
Type: Journal Article/Review
Volume: 15
Parent Publication: EMBO molecular medicine
Issue: 11
ISSN: 1757-4676